This topic contains a solution. Click here to go to the answer

Author Question: A patient receiving alteplase (Activase) for treatment of acute ischemic stroke has a sudden ... (Read 56 times)

Davideckstein7

  • Hero Member
  • *****
  • Posts: 555
A patient receiving alteplase (Activase) for treatment of acute ischemic stroke has a sudden de-crease in level of consciousness. Which of the following conditions should the health care pro-vider suspect?
 
  a. Deep venous thrombosis
  b. Arterial occlusion
  c. Acute myocardial infarction
  d. Cerebral hemorrhage

Question 2

Which of the following patients would not be a candidate for drug therapy with a thrombolytic drug?
 
  a. A patient with a pulmonary embolism
  b. A patient with an acute myocardial infarction
  c. A patient with a confirmed ischemic cerebrovascular accident
  d. A pregnant patient with a deep venous thrombosis



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sailorcrescent

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

ANS: D
Cerebral hemorrhage should be suspected in a patient who has a sudden decrease in level of con-sciousness with thrombolytic drug therapy.

Answer to Question 2

ANS: D
The use of thrombolytic drugs is generally contraindicated during pregnancy.




Davideckstein7

  • Member
  • Posts: 555
Reply 2 on: Jul 23, 2018
Wow, this really help


DylanD1323

  • Member
  • Posts: 314
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library